Transform 1

Transform 1 A prospective, randomized, multicenter study in subjects with small vessels, i.e. at least one de-no

The objective of the study is to compare angiographic outcomes of Magic Touch sirolimus coated balloon (Concept Medical) versus SeQuent Please Neo paclitaxel coated balloon (B.braun) for the treatment of de novo coronary artery lesions in small vessels (≤2.5 mm) with respect to Net Gain (mm) at 6 months follow-up.

09/09/2020

Concept Medical has announced the enrolment of the first patient in the RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch sirolimus coated balloon) by PI Prof. Colombo and a team of GVM Care & Research in Cotignola, Italy. Know more:http://ow.ly/RK8x50BjUkU Supported by Concept Medical & Envision Scientific

04/09/2020
Thank you for featuring enrollment of the first patient in the TRANSFORM-1 RCT (TReAtmeNt of Small coronary vessels: R...
03/09/2020

Thank you for featuring enrollment of the first patient in the TRANSFORM-1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR sirolimus-coated balloon).

Thank you Cath Lab Digest for featuring enrollment of the first patient in the TRANSFORM-1 RCT (TReAtmeNt of Small coron...
03/09/2020

Thank you Cath Lab Digest for featuring enrollment of the first patient in the TRANSFORM-1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch sirolimus-coated balloon).


September 1, 2020 — Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrollment of the first patient in the TRANSFORM-1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch sirolimus-coated balloon).

The first Patient of -1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR sirolimus coated ba...
02/09/2020

The first Patient of -1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR sirolimus coated balloon) has been enrolled by PI Prof. Colombo and a team of GVM, Cotignola, Italy.


Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in the TRANSFORM-1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch sirolimus coated balloon).

On the 1st of September, 2020The first Patient of -1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled tr...
02/09/2020

On the 1st of September, 2020
The first Patient of -1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch sirolimus coated balloon) has been enrolled by PI Prof. Colombo and a team of GVM, Cotignola, Italy.


02/09/2020
02/09/2020

Address

Surat
395007

Website

Alerts

Be the first to know and let us send you an email when Transform 1 posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

TRANSFORM 1

TRANSFORM-1 is a prospective, randomized, multi-centre, European study focusing on coronary artery lesions in small vessels with a head-on comparison between sirolimus coated MagicTouch and paclitaxel-coated SeQuent Please NEO of B. Braun. 114 patients are planned to be randomized 1:1 for Magic Touch or SeQuent Please NEO.